Eton Pharmaceuticals (ETON) - Net earnings per share (EPS TTM)

Symbol and logo of brand etonpharma.com (ETON)

Investments in personnel through financial participation stimulate capital growth, as confirmed by the 12-month rolling earnings per share history, where the current level is approximately 1.50. Eton Pharmaceuticals (ETON) employs an acquisition strategy for undervalued drugs to ensure high margins, while expanding its portfolio through new rights to orphan drugs guarantees sustainable business development within narrow medical niches.

ETON (etonpharma.com) Earnings per share for the last 12 months history from 07/04/2022 to 11/17/2026

Comprehensive metric breakdowns and analytics for Eton Pharma (ETON)

- share price and expert price forecast:
General company analysis:etonpharma.com (ETON)
Mass-produced product of Eton Pharmaceuticals Inc

To identify fundamental sector leaders, analysts utilize the trailing twelve-month (TTM) earnings per share, which measures the actual return on capital adjusted for the total volume of issuance. The TTM net income per share dynamics for Eton Pharmaceuticals (ETON) allow for an assessment of the company's resilience to global raw material supply disruptions and geopolitical risks affecting the cost of developing new drugs.

Competitors of Eton Pharmaceuticals (ETON)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp. (UTHR)|BMRN (BioMarin) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BBIO (BridgeBio)|Earnings per share for the last twelve months bgm.ltd (BGM)|COGT (Cogent Biosciences Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months Xeris Biopharma Holdings XERS|KROS (Keros Pharma) - Earnings per one share for the last 12 months|Arcturus Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year KMDA (Kamada Ltd.)|FULC: Net earnings per share (EPS TTM)|Abeona (ABEO) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months mereobiopharma.com|Net earnings per share for the last 12 months Protalix (PLX)|Earnings per share for the last twelve months Pliant Therapeutics Inc (PLRX)|Net earnings per share for the last 12 months Applied Therapeutics, Inc. APLT|Net earnings per share (EPS TTM) RNTX (aileronrx.com)|Net earnings per share (EPS TTM) Gelteq Limited Inc GELS|Aytu BioPharma, Inc. - Net earnings per share (EPS TTM)|chemomab.com (CMMB) - Net earnings per share for the last 12 months|SRx Health (SRXH) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Polyrizon Ltd. (PLRZ)|Net earnings per share for the last 12 months AEZS|Net earnings per share for the last 12 months Cyclo Therapeutics Inc. (CYTH)|Net earnings per share for the last 12 months INZY (inozyme.com)|RPHM - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CSCI (cosciensbio.com)